WestVac Biopharma Co., Ltd.
Registry sponsor category
Industry
- Other names
- WestVac Biopharma Co., Ltd.
- Company name
- WestVac Biopharma Co., Ltd.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (14)
- A Clinical Study to Evaluate the Safety and Immunogenicity of the Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster
- A Clinical Trial of Immuno-bridging Between Different Manufacture Scales of Recombinant COVID-19 Vaccine (Sf9 Cell)
- A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination
- A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)
- A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.
- A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets
- A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)
- A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination
- Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents
- Phase I Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (WSK-V102)
- Phase II Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell)
- Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster
- Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster
- WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)